Drug recall

Verigene CYP2C19 Nucleic Acid Test (CYP2C19 Test). Each CYP2C19 kit consists of 20 Verigene CYP2C19 Nucleic…

FDA recall event 68710 · Class III · Nanosphere, Inc.

Key facts

Event ID 68710
Recall numbers Z-2559-2014
Recalling firm Nanosphere, Inc.
Product type Devices
Products Verigene CYP2C19 Nucleic Acid Test (CYP2C19 Test). Each CYP2C19 kit consists of 20 Verigene CYP2C19 Nucleic Acid Test Cartridges and 20 Verigene CYP2C19 Nucleic Acid Extraction Trays (with Tip Holder…
Classification Class III
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Nanosphere has recieved reports related to an unacceptable increase in initial no-call rate when performing the Verigene CYP2C19 Nucleic Acid Test (2C19), which has been confirmed through internal…
Initiation date Mar 18, 2014
Report date Sep 3, 2014
Termination date Jul 2, 2015
City Northbrook
State IL
Country United States
FEI number 3006028115

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls